Home > Events > Veristat to attend the european society for medical oncology esmo conference

1 min read

Veristat to Attend the European Society for Medical Oncology (ESMO) Conference

website-image_esmoJoin Veristat and other Oncology researchers, clinicians and patients at the ESMO 2016 Conference, focused on finding the most effective cancer treatment solutions available today.   ESMO 2016 offers a top-notch scientific and educational program created by international experts in oncology.  Some key topic areas include:

  • The Immunotherapy of Cancer
  • Adapting Clinical Trials to Tumor Biology
  • Rare Cancers
  • Patient Networks Driving Cancer Research
  • Cancer Indication Specific Updates and Treatment Breakthroughs
  • And, more

Schedule a Meeting with Veristat

Veristat’s Theresa Bruce and Kath Clayton will be attending ESMO and will be on hand to discuss how Veristat can help you design and execute your cancer trials throughout Europe and North America.

Veristat has helped clients run hundreds of oncology clinical trials for novel drugs, biologics, vaccines, immuno-therapies and diagnostics. We know that even the simplest of clinical trials tasks are much more complex and requires skilled expertise to complete.   Schedule a time to speak with Veristat at ESMO about the challenges you are trying to overcome with your oncology program.

Schedule-a-Meeting-Button-535x165

Share This Event:

   

8 min read

Monthly FDA Guidance and Regulatory News Review - July 2026

This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...

1 min read

Scope of Things Podcast: Daphne Smyth on the Chinese Drug Development Market Expansion

China is rapidly becoming one of the most influential forces in global drug development—but bringing innovative...